Evidence map›Paper›PMID 35116252›Full record

ArticleTranslational cancer research2021

The knowledge, attitude and practice of hospital pharmacists on the safety issues of antitumor agents for the patients discharged in China.

Xiuli Xu, Yuhui Yang, Qianqian Fan, Zhu Zhu

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiuli Xu *Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Yuhui Yang *Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Qianqian FanDepartment of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Zhu ZhuDepartment of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Peking Union Medical College Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient safety is a serious global public health concern, especially for those patients undergoing chemotherapy. The purpose of this pilot study was to assess the knowledge, attitude, and practice among hospital pharmacists in China towards the safety issues of antitumor agents for the patients discharged.

methodsThe pilot study was processed using an online questionnaire targeting hospital pharmacists in China. Ten, five and four questions were used to investigate pharmacists' knowledge, attitude and practice (KAP) respectively.

resultsA total of 360 questionnaires by pharmacists out of 412 (87.4%) were qualified and enrolled. It was found that 58.7% were familiar with safety-related knowledge; 32.2% believed that safety risks exist and 85.3% were willing to provide medication education to patients with cancer who take medication at home after discharge; 91.4%have sometimes taken the initiative to promote safety-related knowledge to their patients.

conclusionsThe research firstly provided some insights into the hospital pharmacists' KAP regarding the safety issues of antitumor agents for patients with cancer discharged in China. Attention should be paid to the knowledge of pharmacists, the awareness of the safety risks of patients with cancer who take medication at home after discharge, and the accessibility to consult with pharmacists after discharge.

Indexed as

antitumor agentsHospital dischargepatient safetypatients with cancerpharmacists’ knowledge-attitude-practice

Identifiers

PMID35116252
PMCPMC8798547
OpenAlexW3128826237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.